Lv1
62 积分 2023-03-27 加入
Streamline: Retrospective Cohort Study of FMS-Like Tyrosine Kinase 3-Mutated Acute Myeloid Leukemia – Real-World Treatment Patterns and Clinical Outcomes of Patients in First Relapse or Refractory Diagnosis
2天前
已完结
Gilteritinib‐based combination therapy in adult relapsed/refractory FLT3 ‐mutated acute myeloid leukaemia
2天前
已完结
SOHO State of the Art Updates and Next Questions Acute Myeloid Leukemia: Current Status and Next Questions
8天前
已完结
Gilteritinib: A Review in Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukaemia
14天前
已完结
Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclax
14天前
已完结
Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax + hypomethylating agent in adults with acute myeloid leukemia: A multicenter retrospective analysis
14天前
已关闭
Contemporary Management of Acute Myeloid Leukemia
14天前
已完结
New drugs creating new challenges in acute myeloid leukemia
14天前
已完结
Azacitidine and its role in the upfront treatment of acute myeloid leukemia
14天前
已完结
Foreign bodies in the aerodigestive tract in pediatric patients
14天前
已完结
皖公网安备34019202002308
